NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announced that top-line data results from its Phase 2a ...

Aarhus, Denmark, 12 February 2026 - NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announced that top-line data ...

Want to give your brain a boost? It might be time for a "synaptic reset." New research suggests that a short midday nap can ...

What is connectomics? The field comprehensively mapping connections between synapses to reshape what we know about the brain.

Neurodegenerative diseases (NDs) are among the most urgent global health challenges, affecting millions worldwide and placing a growing burden on healthcare ...

The biotech is now banking on secondary data signals as it progresses ignaseclant to late-stage trials in Charcot-Marie-Tooth ...

The DGIST Center for Synapse Diversity and Specificity has identified MDGA2 as a novel causative gene for developmental and epileptic encephalopathy (DEE), a rare and intractable neurological disorder ...

Exploratory Phase 2a study showed consistent and clinically meaningful functional improvements across muscle strength, motor performance, and ...

Now, researchers supported by the Knight Initiative for Brain Resilience have discovered clues that may tie synapse loss to another hallmark of brain aging: the declining ability of brain cells to ...

New experiments reveal how astrocytes tune neuronal activity to modulate our mental and emotional states. The results suggest ...

Researchers at CSU engineered recombinant enzymes that produce GABA in the nuclei (cyan) of human neurons (magenta) co-cultured with astrocytes (blue). This system was used to test whether nuclear ...

A research team led by Dr. Àlex Bayés, Head of the Molecular Physiology of the Synapse Group at the Institut de Recerca Sant Pau (IR Sant Pau), has achieved what for decades had been an elusive goal: ...